Soluble Vascular Endothelial Growth Factor Receptor 2 as Predictor of Benefit From Bevacizumab Beyond Progression in Metastatic Colorectal Cancer
Clinical trial NCT02623621 · COMPLETED
Trial details
- NCT number
- NCT02623621
- Sponsor
- Azienda Ospedaliero, Universitaria Pisana
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2015-11-01
- Primary completion
- 2017-10-01
- Enrollment
- 103
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.